clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00396279 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P582 | end time | 2008-04-07 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 37 | |
P4844 | research intervention | (5R)-24,25-Dihydroxyvitamin D | Q27161510 |
calcium oxalate | Q412399 | ||
P580 | start time | 2006-07-10 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | An Open-Label, Multi-Center, Phase 2 Safety and Efficacy Study of Denosumab (AMG 162) in Subjects With Recurrent or Unresectable Giant Cell Tumor (GCT) of Bone |